These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1528 related items for PubMed ID: 19333946

  • 1. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
    González MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M.
    Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
    [Abstract] [Full Text] [Related]

  • 2. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.
    González MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M.
    Gastroenterology; 2009 Mar; 136(3):978-89. PubMed ID: 19135996
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells.
    Gonzalez-Rey E, Chorny A, Varela N, O'Valle F, Delgado M.
    Arthritis Rheum; 2007 Feb; 56(2):531-43. PubMed ID: 17265488
    [Abstract] [Full Text] [Related]

  • 4. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis.
    Gonzalez-Rey E, Anderson P, González MA, Rico L, Büscher D, Delgado M.
    Gut; 2009 Jul; 58(7):929-39. PubMed ID: 19136511
    [Abstract] [Full Text] [Related]

  • 5. Administering human adipose-derived mesenchymal stem cells to prevent and treat experimental arthritis.
    Zhou B, Yuan J, Zhou Y, Ghawji M, Deng YP, Lee AJ, Lee AJ, Nair U, Kang AH, Brand DD, Yoo TJ.
    Clin Immunol; 2011 Dec; 141(3):328-37. PubMed ID: 21944669
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic effect of human amniotic membrane-derived cells on experimental arthritis and other inflammatory disorders.
    Parolini O, Souza-Moreira L, O'Valle F, Magatti M, Hernandez-Cortes P, Gonzalez-Rey E, Delgado M.
    Arthritis Rheumatol; 2014 Feb; 66(2):327-39. PubMed ID: 24504805
    [Abstract] [Full Text] [Related]

  • 7. Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.
    Gonzalez-Rey E, Fernandez-Martin A, Chorny A, Delgado M.
    Arthritis Rheum; 2006 Mar; 54(3):864-76. PubMed ID: 16508968
    [Abstract] [Full Text] [Related]

  • 8. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis.
    Augello A, Tasso R, Negrini SM, Cancedda R, Pennesi G.
    Arthritis Rheum; 2007 Apr; 56(4):1175-86. PubMed ID: 17393437
    [Abstract] [Full Text] [Related]

  • 9. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
    Cao Q, Wang L, Du F, Sheng H, Zhang Y, Wu J, Shen B, Shen T, Zhang J, Li D, Li N.
    Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
    [Abstract] [Full Text] [Related]

  • 10. In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis.
    Delgado M, Toscano MG, Benabdellah K, Cobo M, O'Valle F, Gonzalez-Rey E, Martín F.
    Arthritis Rheum; 2008 Apr; 58(4):1026-37. PubMed ID: 18383372
    [Abstract] [Full Text] [Related]

  • 11. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH, Li XY, Ding J, Jia JF, Zhu P.
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Construction and characterization of a novel DNA vaccine that is potent antigen-specific tolerizing therapy for experimental arthritis by increasing CD4+CD25+Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.
    Song X, Liang F, Liu N, Luo Y, Xue H, Yuan F, Tan L, Sun Y, Xi C, Xi Y.
    Vaccine; 2009 Jan 29; 27(5):690-700. PubMed ID: 19095031
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Transforming growth factor β-transduced mesenchymal stem cells ameliorate experimental autoimmune arthritis through reciprocal regulation of Treg/Th17 cells and osteoclastogenesis.
    Park MJ, Park HS, Cho ML, Oh HJ, Cho YG, Min SY, Chung BH, Lee JW, Kim HY, Cho SG.
    Arthritis Rheum; 2011 Jun 29; 63(6):1668-80. PubMed ID: 21384335
    [Abstract] [Full Text] [Related]

  • 18. GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis.
    van Hamburg JP, Mus AM, de Bruijn MJ, de Vogel L, Boon L, Cornelissen F, Asmawidjaja P, Hendriks RW, Lubberts E.
    Arthritis Rheum; 2009 Mar 29; 60(3):750-9. PubMed ID: 19248112
    [Abstract] [Full Text] [Related]

  • 19. Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation.
    Carrión F, Nova E, Luz P, Apablaza F, Figueroa F.
    Immunol Lett; 2011 Mar 30; 135(1-2):10-6. PubMed ID: 20888363
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 77.